SRI International
-
Evaluation of the efficacy of the hypocretin/orexin receptor agonists TAK-925 and ARN-776 in narcoleptic orexin/tTA; TetO-DTA mice
We evaluated the efficacy of two small molecule hypocretin/orexin receptor-2 (HCRTR2) agonists in narcoleptic male orexin/tTA; TetO-DTA mice.
-
Assessment of Immunologically Potent Carbohydrates
We present here our laboratory protocols for performing carbohydrate ELISA and discuss several assay platforms that may be applied complementarily to explore the carbohydrate moieties that are critical for host immune recognition and induction of glycan-specific antibody responses.
-
SRI scientists are developing therapeutics to help fight the next pandemic
The institute received a four-year, $4.95 million award from the National Institute of Allergy and Infectious Diseases.
-
Dan Cohen
Dan Cohen, Senior Education Researcher, SRI Education
-
Spearheading Innovations in STEM & CS | News from SRI Education | February 2023
This month’s newsletter highlights key STEM & CS projects that are having a positive effect in the field, the researchers behind this impactful work, and recent STEM & CS publications.
-
![A move towards multilingual: why this term is better than others [for now]](https://www.sri.com/wp-content/uploads/2023/02/A-move-towards-Multilingual-newsletter.png)
A move towards multilingual: why this term is better than others [for now]
The terms we use to describe students who speak two or more languages or speak a language other than English at home impacts how we envision and develop programs and policies for those students.
-
An SRI technology helps people with Duchenne muscular dystrophy and spinal muscular atrophy maintain the use of their arms
The Duchenne UK charity will utilize SRI’s twisted string actuator technology in their wearable SMART suit.
-
Ellen Ochoa
Veteran Astronaut, Director of NASA Johnson Space Center (retired)
-
SRI welcomes Ellen Ochoa to the board of directors
Ochoa is a former astronaut, former Director of NASA’s Johnson Space Center, and until May 2022, chair of the National Science Board.
-
Going Beyond the Blood-Brain Barrier: Delivery of Diverse Cargo to Targeted Cells Within the Central Nervous System, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn about going beyond the blood-brain barrier through the delivery of diverse cargo within the central nervous system (CNS).
-
Scientists at SRI International have developed a peptide that targets lung tumors and delivers therapeutics inside the cells
The newly optimized molecular vehicle provides effective, targeted delivery of anticancer agents to lung tumors.
-
SRI International appoints Kathlynn Brown to Biosciences Division President
The SRI International veteran to expand leadership for the innovations needed to cure diseases and improve people’s health.